Christophe Bourdon, Leo Pharma CEO
October 4, 2022 03:39 PM EDTUpdated October 6, 08:55 AM
Pharma
Marketing

Leo Phar­ma looks 'be­yond the skin' in atopic der­mati­tis aware­ness cam­paign

Nicole DeFeudis

Editor

As Leo Phar­ma aims to take on heavy­weight champ Dupix­ent in atopic der­mati­tis, the com­pa­ny is launch­ing “AD Days Around the World,” an aware­ness cam­paign …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times